Drug Shortage Report for NALOXONE HYDROCHLORIDE INJECTION
| Report ID | 102920 |
| Drug Identification Number | 02393034 |
| Brand name | NALOXONE HYDROCHLORIDE INJECTION |
| Common or Proper name | Naloxone Hydrochloride Injection |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | NALOXONE HYDROCHLORIDE |
| Strength(s) | 0.4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 x 10mL vial / fiole |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-01-31 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2024-10-14 |
| Shortage status | Resolved |
| Updated date | 2024-12-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | [email protected] - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-12-04 | French | Compare |
| v4 | 2024-12-04 | English | Compare |
| v3 | 2020-02-01 | English | Compare |
| v2 | 2020-01-09 | French | Compare |
| v1 | 2020-01-09 | English | Compare |
Showing 1 to 5 of 5